Bibliographic Info
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Very low
For a child or adolescent with severe anaemia (<7.5 g/dl) or severe neutropenia (<500 cells/mm3), the preferred regimen is nevirapine (NVP) + 2 nucleoside reverse transcriptase inhibitor (NRTI) (avoid zidovudine (AZT)).